Folks please take a long look at MILV. A stock returning from the dead, and all the DD shows it is planning a huge move to Nasdaq as Biotech. All the DD is in stickies. Google "Liposomes, Michael W Fountain", or check my DD posts and Drugmans for quick detailed facts.
MILV has filled SEC fillings and the first of many financials going back 10 years, filled 8-Ks for the new accountant, expecting a R/M SEC filling, possibly today, based a shareholder meeting Last week that was announced in snail mail letters to the shareholders. It announced the meeting plans...... Older SEC fillings show Fountain as the inventor, 10% owner of CCA, Compelling Competing Advantage LLC, which Fountain filled an SEC filling in his name showing him as a major shareholder of the non-trading CCA firm that is taking over MILV.
The shareholders letter confirmed 2016 SEC fillings that showed CCA with a Penn state University Research contract that was to be moved to MILV last week (expecting the 8-k any time now).
The SEC fillings in 2016 said the research is using Fountains Liposome Nano Probe tech to go where no drug has gone before, to cross the blood brain barrier and safely deliver MRI dyes and drugs to parts of the brain not currently possible to do safely, to repair brain trauma. One of the major share holders is a two time Penn State Univ Super bowl champ!!!
That is just 5% of the DD I have done. I have about 10,000 pages more. Like 131 issued international patents by Fountain spanning 40 years. 180 international products licensing his patents from his resume at one of 4 universities where he is a full professor!!!
All of my posts are strictly opinions and should not be considered to be facts, or investment advise. They are for entertainment purposes only.
